Trump reports state participation in Medicaid drug pricing arrangement
The Hill · September 18, 2026Original source ↗
What happened
President Trump announced that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in a program aimed at reducing drug prices for Medicaid programs. He noted that 40 states and Puerto Rico have already signed agreements. The Centers for Medicare and Medicaid Services is overseeing the arrangement.
Why it matters
This development could potentially lower prescription drug costs for Medicaid recipients.
How this story affects people
How does this story affect you if you are a Medicaid recipient?
This program could lower your prescription drug costs, making medications more affordable and accessible. As more states sign agreements, you may see immediate benefits in your healthcare expenses.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your RippleMore stories
- HealthCourt permits relocation of baby born via surrogate for medical treatment
- HealthCongo starts Ebola vaccinations for health workers in outbreak area
- HealthCalifornia issues measles exposure alert following unvaccinated passenger travel
- HealthCDC report shows income influences consumption of fresh produce among US adults